| |
|
Form Serial Number: |
DA20240115E00015
|
| 1.
Date of relevant event: |
12/01/2024
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01672 |
| 4.
Name of listed corporation: |
Ascletis Pharma Inc. - B |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
1,044,821,000 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
WU |
| (Other names) |
Judy Hejingdao |
|
|
|
| 10.
Name of director (Chinese): |
何淨島 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1711 | Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2103 | Interests held jointly with another person |
|
|
1,155,500 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 601,532,078 | 57.57 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 601,532,078 | 57.57 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2202 | Interest of your spouse |
| |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4104 | Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| 03/01/2024 | 02/01/2034 | | | HKD | 1.448 | | | 1,000,000 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| Spouse | Jinzi Jason WU | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Lakemont Remainder Trust | J.P. Morgan Trust Company of Delaware, Trustee, 500 Stanton Christiana Road, NCC2, Floor 02, Newark, DE 19713, United States | Judy Hejingdao WU | 100.00 | N | |
| Lakemont Holding LLC | The Corporation Trust Company, Corporate Trust Center, 1209 Orange Street, Wilmington, DE 19801, United States | Lakemont Remainder Trust | 45.95 | Y | |
| Northridge Trust | J.P. Morgan Trust Company of Delaware, Trustee, 500 Stanton Christiana Road, NCC2, Floor 02, Newark, DE 19713, United States | Judy Hejingdao WU | 100.00 | N | |
| Lakemont Holding LLC | The Corporation Trust Company, Corporate Trust Center, 1209 Orange Street, Wilmington, DE 19801, United States | Northridge Trust | 53.52 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| Lakemont Remainder Trust | Addresses of individuals are not displayed. | | |
| Northridge Trust | Addresses of individuals are not displayed. | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Box 24: On January 12, 2024 (Hong Kong time), 1,155,500 ordinary shares were transferred to the account of Dr. Jinzi Jason WU and 1,155,500 ordinary shares were transferred to the account of Mrs. Judy Hejingdao WU from the joint account of them. Box 28: Such shares represent the share options granted to Mrs. Wu under the share option scheme of the Company.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
15/01/2024
(dd/mm/yyyy)
|
| |